CD Private Equity Fund III Overview
Get informed when a big investor buys or sells
+ Follow8.23%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for CD3.AX is 8.23%. That is below the sector sector average of 11.64%. Investors often review this figure alongside CD Private Equity Fund III's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, CD3.AX currently prints 8.23% for ROE, while the sector average sits near 11.64%. That is roughly 29.2% below the sector mean. Large gaps often invite a closer look at CD Private Equity Fund III's growth, margins, and balance sheet.
Return on Equity shows how effectively CD Private Equity Fund III converts resources into returns. At 8.23%, CD3.AX may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CD3.AX's ROE (8.23%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
